Walleye Trading
TVTX icon

Walleye Trading’s Travere Therapeutics TVTX Stock Holding History

Walleye Trading’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+1,901
New +$84.3K ﹤0.01% 3376
2026
Q1 		– Sell
-374
Closed -$14.3K – 4741
2025
Q4 		$14.3K Sell
374
-2,595
-87% -$84.4K ﹤0.01% 4136
2025
Q3 		$71K Buy
+2,969
New +$55.8K ﹤0.01% 3844
2023
Q3 		– Sell
-34,759
Closed -$534K – 5377
2023
Q2 		$534K Buy
+34,759
New +$632K ﹤0.01% 2692
2023
Q1 		– Sell
-22,260
Closed -$468K – 5426
2022
Q4 		$468K Sell
22,260
-9,590
-30% -$203K ﹤0.01% 2856
2022
Q3 		$785K Buy
+31,850
New +$823K ﹤0.01% 2463
2022
Q1 		– Sell
-3,114
Closed -$97K – 5931
2021
Q4 		$97K Sell
3,114
-24,182
-89% -$681K ﹤0.01% 4392
2021
Q3 		$662K Buy
+27,296
New +$502K ﹤0.01% 2652
2021
Q1 		– Sell
-2,191
Closed -$60K – 5315
2020
Q4 		$60K Buy
+2,191
New +$51.2K ﹤0.01% 4129
2020
Q1 		– Sell
-12,909
Closed -$183K – 4583
2019
Q4 		$183K Buy
+12,909
New +$165K ﹤0.01% 3219
2019
Q2 		– Sell
-4,637
Closed -$105K – 4502
2019
Q1 		$105K Buy
4,637
+2,690
+138% +$59.4K ﹤0.01% 3438
2018
Q4 		$44K Sell
1,947
-1,344
-41% -$33.4K ﹤0.01% 4184
2018
Q3 		$95K Buy
+3,291
New +$94.1K ﹤0.01% 4239
2018
Q1 		– Sell
-2,240
Closed -$47 – 4814
2017
Q4 		$47 Buy
+2,240
New +$51.2K ﹤0.01% 4032
2017
Q3 		– Sell
-700
Closed -$14 – 4607
2017
Q2 		$14 Sell
700
-1,200
-63% -$21.8K ﹤0.01% 4205
2017
Q1 		$35 Buy
+1,900
New +$37.2K ﹤0.01% 3943
2015
Q4 		– Sell
-3,600
Closed -$73K – 5693
2015
Q3 		$73K Buy
3,600
+3,300
+1,100% +$97.8K ﹤0.01% 3209
2015
Q2 		$10K Buy
+300
New +$8.22K ﹤0.01% 4308

Other funds holding TVTX

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PIP
Palisades Investment Partners Santa Monica, California $352M AUM 76.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Walleye Trading's TVTX Position: Q2 2026 in Review

Walleye Trading opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 1,901 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3376 among its holdings. This is a return to the name: Walleye Trading previously reported a position in TVTX as recently as Q4 2025.

Walleye Trading first reported a position in TVTX in Q2 2015 and has held it in 18 quarters since. The position peaked at $785K in Q3 2022. 71 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Walleye Trading held 1,901 shares of Travere Therapeutics worth $108K as of Q2 2026.
  • Travere Therapeutics was a new Walleye Trading position in Q2 2026.
  • Travere Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3376 holding.
  • Walleye Trading first reported a position in Travere Therapeutics in Q2 2015 and has held it in 18 quarters since.
  • Walleye Trading's Travere Therapeutics position peaked at $785K in Q3 2022.
  • 71 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.